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In a recent issue of the Journal, Duckett et al. (1) published a study
indicating that the acute hemodynamic response ([AHR], assessed
by LVdP/dtmax, the maximum rate of rise of left ventricular
pressure) predicts reverse remodeling ([RR], which is the decrease
in left ventricular end-systolic volume) in recipients of cardiac
resynchronization therapy (CRT). At first glance, these results
seem long-awaited and fit with physiological ideas about the action
of CRT. In an editorial comment, Bozkurt and Ramasubbu (2)
mention that “whether a nonresponse to early surrogate testing will
identify the chronic nonresponder to CRT, with respect to hard
clinical endpoints, remains to be answered.” Recently, we investi-
gated the relation between LVdP/dtmax and survival in the
majority of CRT patients treated in 2 centers over a 5-year period
(n  285) (3). Absolute LVdP/dtmax at baseline predicted 1-year
mortality (hazard ratio: 0.79), but the change in LVdP/dtmax upon
RT had no relation to outcome. As frequent users of LVdP/
tmax for CRT optimization, we were initially surprised and
disappointed by these findings. However, the data are strong and
consistent with a recent Japanese study (4). Therefore, we think
that there is stronger evidence against than in favor of a relation
between AHR and long-term outcome. The apparently contradic-
tory findings by Duckett et al. (1) may be (in part) explained by
several limitations of their study: 1) its sample size was small (n 
32), explaining why adjusting the cutoff value for percentage of
change in LVdP/dtmax from 10% to 11.1% (a small difference,
onsidering the 8% baseline drift in LVdP/dtmax), increased
specificity from 64% to 86%; 2) switching from natural sinus
rhythm to atrial pacing caused an unusually large (11%) increase
in LVdP/dtmax; 3) it is not mentioned whether these patients were
a selected subgroup or consecutive patients; 4) the relation between
AHR and RR was only evaluated by dichotomously separating
responders and nonresponders, without showing a scatter plot or
linear regression; and 5) it was not reported whether absolute
baseline LVdP/dtmax related to RR. Because baseline LVdP/dtmax
strongly determines percentage of change in LVdP/dtmax, it may
seem that the percentage of change in LVdP/dtmax relates to RR,
although it is actually the absolute baseline value. Summarizing, we
think that there are some questions regarding the reported relation
between AHR and RR (1) and that there is even less evidence to
support using AHR to predict long-term outcome in CRT.
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Reply
We thank Dr. Prinzen and colleagues for their interest in our study
(1). They comment that our results fit with physiological concepts
regarding cardiac resynchronization therapy but are not supported
by their findings that baseline rather than change in (the maximum
rate of LV pressure rise LVdP/dtmax) predicted survival (2).
We acknowledge that our study was limited by a small sample
ize and that our patients were a selected group meeting criteria for
n inclusive research protocol. We used a 10% rise in LVdP/dtmax
to define acute response, which was supported by the receiver-
operator analysis giving a cutoff of 11.1%, although this small
increase did change the specificity to 86% from 64%. We found a
moderate correlation between percentage rise in LVdP/dtmax and
extent of remodeling (r  0.6) but no relationship between
baseline LVdP/dtmax and remodeling. We used baseline atrial
acing to account for heart rate changes causing a rise in dP/dtmax
as described previously and our baseline dP/dtmax was comparable
o the reported study (2).
We note the findings of Bogaard et al. (2) and would like to
ighlight several important differences between studies. Their
atient population was different and predominantly ischemic: 56%
ersus 36% in our study. It is well described that cardiac resyn-
hronization therapy response is worse in ischemic cardiomyopa-
hy and 70% of their patients with events had ischemic cardiomy-
pathy (2). Importantly, we used LVdp/dtmax to guide left
